Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

NCT04005976 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT04005976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2016
Completion date
January 1, 2037
Enrollment
5,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm, aortic diseases, aortic dissection